FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $20,210,000 | -2.0% | 2,551,794 | 0.0% | 0.20% | +36.1% |
Q2 2021 | $20,618,000 | -24.6% | 2,551,794 | 0.0% | 0.15% | -53.9% |
Q1 2021 | $27,355,000 | -8.8% | 2,551,794 | 0.0% | 0.32% | -3.9% |
Q4 2020 | $29,984,000 | -2.2% | 2,551,794 | 0.0% | 0.33% | -39.6% |
Q3 2020 | $30,673,000 | -31.2% | 2,551,794 | 0.0% | 0.55% | -30.1% |
Q2 2020 | $44,580,000 | – | 2,551,794 | – | 0.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 2,973,744 | $24,028,000 | 4.99% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12,613,000 | 4.97% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29,658,000 | 3.03% |
Sio Capital Management, LLC | 266,107 | $2,150,000 | 0.53% |
Orbimed Advisors | 3,224,770 | $26,056,000 | 0.26% |
Perceptive Advisors | 3,550,334 | $28,686,000 | 0.19% |
AlphaCentric Advisors LLC | 71,500 | $578,000 | 0.16% |
Rock Springs Capital Management LP | 948,327 | $7,662,000 | 0.15% |
TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20,618,000 | 0.15% |
Artal Group S.A. | 750,000 | $6,060,000 | 0.12% |